HomeRVU • WSE
add
Ryvu Therapeutics SA
Previous close
zł 49.60
Day range
zł 48.00 - zł 51.00
Year range
zł 47.00 - zł 72.40
Market cap
1.12B PLN
Avg Volume
5.10K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
(PLN) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 23.01M | 53.08% |
Operating expense | 52.24M | 27.46% |
Net income | -30.42M | -6.71% |
Net profit margin | -132.18 | 30.29% |
Earnings per share | — | — |
EBITDA | -30.26M | -9.58% |
Effective tax rate | -0.35% | — |
Balance Sheet
Total assets
Total liabilities
(PLN) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 254.20M | 25.66% |
Total assets | 406.65M | -4.38% |
Total liabilities | 201.24M | 64.99% |
Total equity | 205.41M | — |
Shares outstanding | 23.12M | — |
Price to book | 5.59 | — |
Return on assets | -20.31% | — |
Return on capital | -29.93% | — |
Cash Flow
Net change in cash
(PLN) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -30.42M | -6.71% |
Cash from operations | -22.05M | 10.46% |
Cash from investing | -25.46M | 85.92% |
Cash from financing | 34.55M | 287,841.67% |
Net change in cash | -17.25M | 91.67% |
Free cash flow | 13.19M | 1,445.94% |
About
Founded
2007
Website
Employees
270